11
|
Dackus GMHE, Ter Hoeve ND, Opdam M, Vreuls W, Koop EA, Varga Z, Willems SM, Van Deurzen CHM, Groen EJ, Cordoba-Iturriagagoitia A, Bart J, Mooyaart AL, Van den Tweel JG, Zolota V, Wesseling J, Sapino A, Chmielik E, Ryska A, Broeks A, Stathonikos N, Jozwiak K, Hauptmann M, Sonke GS, Van der Wall E, Siesling S, Van Diest PJ, Linn SC. Abstract P5-08-07: The long-term prognosis of breast cancers patients diagnosed ≤40 years in the absence of adjuvant systemic therapy. Cancer Res 2017. [DOI: 10.1158/1538-7445.sabcs16-p5-08-07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
This abstract was withdrawn by the authors.
Collapse
Affiliation(s)
- GMHE Dackus
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - ND Ter Hoeve
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - M Opdam
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - W Vreuls
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - EA Koop
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - Z Varga
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - SM Willems
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - CHM Van Deurzen
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - EJ Groen
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - A Cordoba-Iturriagagoitia
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - J Bart
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - AL Mooyaart
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - JG Van den Tweel
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - V Zolota
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - J Wesseling
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - A Sapino
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - E Chmielik
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - A Ryska
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - A Broeks
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - N Stathonikos
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - K Jozwiak
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - M Hauptmann
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - GS Sonke
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - E Van der Wall
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - S Siesling
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - PJ Van Diest
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| | - SC Linn
- Netherlands Cancer Institute, Amsterdam, Netherlands; University Medical Center Utrecht, Utrecht, Netherlands; Canisius Wilhelmina Ziekenhuis, Nijmegen, Netherlands; Gelre Ziekenhuis, Apeldoorn, Netherlands; Institute of Surgical Pathology, University Hospital Zurich, Zurich, Switzerland; Erasmus MC Cancer Institute, Rotterdam, Netherlands; The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands; Servicio de Dermatología, Complejo Hospitalario de Navarra, Navarra, Spain; Isala Klinieken Zwolle, Zwolle, Netherlands; Leiden University Medical Center, Leiden, Netherlands; Rion University Hospital, University of Patras, Medical School, Patras, Greece; Candiolo Cancer Institute – FPO, IRCCS, Italy; Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland; Charles University in Prague, Faculty of Medicine and University Hospital, Hradec Kralove, Czech Republic; Core Facility Molecular Pathology and Biobanking, Netherlands Cancer Institute, Amsterda
| |
Collapse
|